Showing 1 - 4 results of 4 for search 'John Lister' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • John Lister
Showing 1 - 4 results of 4 for search 'John Lister', query time: 0.06s Refine Results
  1. 1
    USA EXPERIENCE: IN-HOUSE PREPARATION: PROSPECTS AND PROBLEMS

    USA EXPERIENCE: IN-HOUSE PREPARATION: PROSPECTS AND PROBLEMS by Albert Donnenberg, John Lister

    Published 2022-10-01
    Get full text
    Article
  2. 2
    A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells

    A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells by Vera S. Donnenberg, Vera S. Donnenberg, Vera S. Donnenberg, James D. Luketich, James D. Luketich, Ibrahim Sultan, Ibrahim Sultan, John Lister, John Lister, David L. Bartlett, David L. Bartlett, Sohini Ghosh, Albert D. Donnenberg, Albert D. Donnenberg, Albert D. Donnenberg

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Palifermin Compared to Supersaturated Calcium Phosphate Rinse in Prevention of Severe Oral Mucositis after Stem Cell Transplantation in Patients Receiving Radiotherapy-Based Myeloablative Conditioning

    Palifermin Compared to Supersaturated Calcium Phosphate Rinse in Prevention of Severe Oral Mucositis after Stem Cell Transplantation in Patients Receiving Radiotherapy-Based Myeloa... by Tarik Hadid, Ayad Al-Katib, Jose Binongo, Gina M. Berteotti, Salman Fazal, James M. Rossetti, John Lister

    Published 2023-02-01
    Get full text
    Article
  4. 4
    An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes

    An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes by Stuart L. Goldberg, Pierre Fenaux, Michael D. Craig, Emmanuel Gyan, John Lister, Jeannine Kassis, Arnaud Pigneux, Gary J. Schiller, JungAh Jung, E. Jane Leonard, Howard Fingert, Peter Westervelt

    Published 2014-01-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs